血管内皮生长因子受体2(VEGFR2)重组蛋白

血管内皮生长因子受体2(VEGFR2)重组蛋白

Recombinant Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)

CD309; FLK1; VEGFR; KDR; A Type III Receptor Tyrosine Kinase; Kinase Insert Domain Receptor; Kinase Insert Domain Receptor; Fetal Liver Kinase-1

[ PROPERTIES ]

Source: Prokaryotic expression

Host: E.coli

Residues: Asn46~Thr320

Tags: N-terminal His Tag

Subcellular Location: Membrane, Nucleus, Cytoplasm

Purity: > 90%

Traits: Freeze-dried powder

Buffer formulation: PBS, pH7.4, containing 0.01% SKL.

Original Concentration: 200µg/mL

Applications: Positive Control; Immunogen; SDS-PAGE; WB.

(May be suitable for use in other assays to be determined by the end user.)

Predicted isoelectric point: 6.2

Predicted Molecular Mass: 34.8kDa

Accurate Molecular Mass: 35kDa as determined by SDS-PAGE reducing conditions.

[ USAGE ]

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

[ STORAGE AND STABILITY ]

Storage: Avoid repeated freeze/thaw cycles.

 Store at 2-8ºC for one month.

 Aliquot and store at -80ºC for 12 months.

Stability Test: The thermal stability is described by the loss rate. The loss rate was determinedby accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and noobvious degradation and precipitation were observed. The loss rate is less than 5% within theexpiration date under appropriate storage condition.

[ SEQUENCE ]

[ IMPORTANT NOTE ]

The kit is designed for research use only, we will not be responsible for any issue if the kit wasused in clinical diagnostic or any other procedures.

特别提示：本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！